{"version":"1.0","type":"link","title":"Immunotherapy in uncommon EGFR-mutant NSCLC: Revisiting a therapeutic gray zone.","author_name":"Lim JH 외","author_url":"https://prs-insight.online/author/Lim%20JH","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/96404","thumbnail_width":1200,"thumbnail_height":630}